Heart failure with preserved ejection fraction: An insight into its prevalence, predictors, and implications of early detection

Reviews in Cardiovascular Medicine

Volumn 16, Issue 1, 2015, Pages 20-27

  Asrar ul Haq, Muhammad ^a,b,c   Wong, Chiew ^a,b,d   Hare, David L ^b,c  

^a NORTHERN HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTIN HEALTH   (Australia)

^d WESTERN HEALTH   (Australia)

Author keywords

Diastolic dysfunction; Heart failure; Heart failure with normal ejection fraction; Heart failure with preserved ejection fraction

Indexed keywords

ANEMIA; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; EARLY DIAGNOSIS; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; HYPERTENSION; LUNG DISEASE; MORBIDITY; OBESITY; PREVALENCE;

EID: 84927655239     PISSN: 15306550     EISSN: 21538174     Source Type: Journal    
DOI: 10.3909/ricm0725     Document Type: Article

References (63)

1. Asrar ul Haq M, Wong C. Heart failure with preserved myocardial contractility: understanding the pathophysiology. Eur J Health. 2013(2013): Article ID 6.
2. Asrar Ul Haq M, Wong C, Levinger I, et al. Effect of exercise training on left ventricular remodeling in diabetic patients with diastolic dysfunction: rationale and design. Clin Med Insights Cardiol. 2014;8:23-28.
3. Asrar ul Haq M, Wong C, Mutha V, et al. Therapeutic interventions for heart failure with preserved ejection fraction: a summary of current evidence. World J Cardiol. 2014;6:67-76.
4. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation. 2002;105:1503-1508.
5. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105:1387-1393.
6. Becker M, Bilke E, Kühl H, et al. Analysis of myocardial deformation based on pixel tracking in two dimensional echocardiographic images enables quantitative assessment of regional left ventricular function. Hear t. 2006;92:1102-1108.
7. Notomi Y, Martin-Miklovic MG, Oryszak SJ, et al. Enhanced ventricular untwisting during exercise: a mechanistic manifestation of elastic recoil described by Doppler tissue imaging. Circulation. 2006;113:2524-2533.
8. Skaluba SJ, Litwin SE. Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation. 2004;109:972-977.
9. Hadano Y, Murata K, Yamamoto T, et al. Usefulness of mitral annular velocity in predicting exercise tolerance in patients with impaired left ventricular systolic function. Am J Cardiol. 2006;97:1025-1028.
10. Asrar ul Haq M, Mutha V, Lin T, et al. Left ventricular torsional dynamics post exercise for LV diastolic function assessment. Cardiovasc Ultrasound. 2014;12:8.
11. Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients. or 5 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001;87:413-419.
12. O'Connor CM, Gattis WA, Shaw L, et al. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol. 2000;86:863-867.
13. Smith GL, Masoudi FA, Vaccarino V, et al. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol. 2003;41:1510-1518.
14. Fischer M, Baessler A, Hense H W, et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographicbased survey of a population sample. Eur Heart J. 2003;24:320-328.
15. Fonarow GC, Stough WG, Abraham WT, et al; OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50:768-777.
16. Yancy CW, Lopatin M, Stevenson LW, et al; ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006;47:76-84.
17. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000;102:470-479.
18. Lakatta EG. Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev. 2002;7:29-49.
19. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res. 1991;68:1560-1568.
20. Anversa P, Palackal T, Sonnenblick EH, et al. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res. 1990;67:871-885.
21. Kitzman DW, Daniel KR. Diastolic heart failure in the elderly. Clin Geriatr Med. 2007;23:83-106.
22. Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948-1955.
23. Phillips RA, Goldman ME, Ardeljan M, et al. Determinants of abnormal left ventricular filling in early hypertension. J Am Coll Cardiol. 1989;14:979-985.
24. Asrar ul Haq M, Mutha V, Rudd N, Wong C. Diabetic cardiomyopathy-what do we know about it? World J Cardiovasc Dis. 2013;3:26-32.
25. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol. 2001;87:320-323.
26. Liu JE, Robbins DC, Palmieri V, et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll Cardiol. 2003;41:2022-2028.
27. Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001;103:2668-2673.
28. Hardin NJ. The myocardial and vascular pathology of diabetic cardiomyopathy. Coron Artery Dis. 1996;7:99-108.
29. Powell BD, Redfield MM, Bybee KA, et al. Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. Am J Cardiol. 2006;98:116-120.
30. Barberà JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J. 2003;21:892-905.
31. Baum GL, Schwartz A, Llamas R, Castillo C. Left ventricular function in chronic obstructive lung disease. N Engl J Med. 1971;285:361-365.
32. Schena M, Clini E, Errera D, Quadri A. Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale. Chest. 1996;109:1446-1451.
33. Gomez A, Mink S. Increased left ventricular stiffness impairs filling in dogs with pulmonary emphysema in respiratory failure. J Clin Invest. 1986;78:228-240.
34. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-1904.
35. Bradley TD, Hall MJ, Ando S, Floras JS. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest. 2001;119:1827-1835.
36. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1999;34:890-911.
37. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282-2289.
38. Cohn JN, Johnson G. Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation. 1990;81(2 suppl):III48-III53.
39. Judge K W, Pawitan Y, Caldwell J, et al. Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry. J Am Coll Cardiol. 1991;18:377-382.
40. McKee PA, Castelli W P, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441-1446.
41. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194-202.
42. Zile MR, Gaasch WH, Anand IS, et al; I-Preserve Investigators. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation. 2010;121:1393-1405.
43. Hunt SA; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1-e82.
44. Takemoto Y1, Barnes ME, Seward JB, et al. Usefulness of left atrial volume in predicting first congestive heart failure in patients. or 5 65 years of age with well-preserved left ventricular systolic function. Am J Cardiol. 2005;96:832-836.
45. Tsang TS, Barnes ME, Gersh BJ, et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol. 2003;42:1199-1205.
46. Correa de Sa DD, Hodge DO, Slusser J P, et al. Progression of preclinical diastolic dysfunction to the development of symptoms. Heart. 2010;96:528-532.
47. Jones RC, Francis GS, Lauer MS. Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol. 2004;44:1025-1029.
48. Olsson LG, Swedberg K, Ducharme A, et al; CHARM Investigators. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol. 2006;47:1997-2004.
49. Tsang TS, Gersh BJ, Appleton C P, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol. 2002;40:1636-1644.
50. Mamas MA, Caldwell JC, Chacko S, et al. A metaanalysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail. 2009;11:676-683.
51. O'Meara E, Clayton T, McEntegart MB, et al; CHARM Committees and Investigators. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation. 2006;113:986-994.
52. Felker GM, Shaw LK, Stough WG, O'Connor CM. Anemia in patients with heart failure and preserved systolic function. Am Heart J. 2006;151:457-462.
53. Latado AL, Passos LC, Darzé ES, Lopes AA. Comparison of the effect of anemia on in-hospital mortality in patients with versus without preserved left ventricular ejection fraction. Am J Cardiol. 2006;98:1631-1634.
54. Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol. 2008;52:501-511.
55. Kupari M, Lindroos M, Iivanainen AM, et al. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J Intern Med. 1997;241:387-394.
56. Morgan S, Smith H, Simpson I, et al. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey. BMJ. 1999;318:368-372.
57. Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J. 1999;20:447-455.
58. Yip GW, Ho PP, Woo KS, Sanderson JE. Comparison of frequencies of left ventricular systolic and diastolic heart failure in Chinese living in Hong Kong. Am J Cardiol. 1999;84:563-567.
59. Devereux RB, Roman MJ, Liu JE, et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol. 2000;86:1090-1096.
60. Cortina A, Reguero J, Segovia E, et al. Prevalence of heart failure in Asturias (a region in the north of Spain). Am J Cardiol. 2001;87:1417-1419.
61. Hedberg P, Lönnberg I, Jonason T, et al. Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study. Eur Heart J. 2001;22:676-683.
62. Ceia F, Fonseca C, Mota T, et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail. 2002;4:531-539.
63. Abhayaratna W P, Smith WT, Becker NG, et al. Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study. Med J Aust. 2006;184:151-154.